Participation of Clinical Pharmacist in the Therapy for One Case of Pneumocystis Jiroveci Pneumonia after Liver Transplantation

OBJECTIVE To investigate the therapeutic regimen of pneumocystis jiroveci infection and the role of clinical pharmacists in the treatment of pneumocystis jiroveci infection. METHODS Clinical pharmacists participated in the treatment of pneumocystis jiroveci pneumonia in a patient with renal insufficiency after liver transplantation. Meanwhile, the clinical manifestations and treatment of pneumocystis jiroveci pneumonia infection were analyzed by reference to literature at home and abroad. RESULTS The doctor adopted the suggestion of clinical pharmacist, and the patient's infection was controlled with the condition improved, and the patient was discharged. CONCLUSION Pneumocystis jiroveci infection shall be recognized early in transplant recipients. Patients with mild renal insufficiency may consider the use of low-dose combination of compound sulfamethoxazole and caspofungin in the treatment of pneumocystis jiroveci infection.